3:35 PM
 | 
Jan 05, 2018
 |  BC Extra  |  Company News

Reports: Acorda exploring sale

Acorda Therapeutics Inc. (NASDAQ:ACOR) gained $2.50 (12%) to $23.55 on Friday after media reports that the company is exploring a possible sale....

Read the full 89 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >